Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is […]
About Anthony StrzalekThis author has not yet filled in any details.
So far Anthony Strzalek has created 16 blog entries.
Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.
Patients “will bear the brunt of this hardship” says Jump, who […]
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the […]
Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.
Hayes talks about the accuracy of the device’s deployment around the thoracic […]
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about the “limitations of the current clunky stenting paradigm” and how the […]
A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.
Opening the session, Stéphan Haulon and his team […]
Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session.
New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon aloneAnthony Strzalek2019-04-30T17:29:51+01:00
Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.
Edmonds discusses why “too many legs are being lost” and Serena talks […]
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”
Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]
Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]
Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level dataAnthony Strzalek2019-04-17T11:51:20+01:00
There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.
Cook Medical has just announced the release of de-identifiable […]
Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.
Ladich believes that “we need to take a step […]
In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.
Ross Naylor and Peter Schneider debated the impact of new technologies and innovations […]